AtriCure (ATRC) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.78 +1.30%
EPS Growth %: +92.3%
Financial Fact:
Other: -32K
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +92.3%
Financial Fact:
Other: -32K
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.32), $0.03 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $84.5 million versus the consensus estimate of $79.67 million.
GUIDANCE:
AtriCure sees FY2022 EPS of ($1.07)-($1.12), versus the consensus of ($1.10). AtriCure sees FY2022 revenue of $323-333 million, versus the consensus of $324.43 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- RH (RH) Tops Q1 EPS by 12c
- Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
